For instance, in a mouse model of GBM, the SDF-1α inhibitor in combination with VEGF blockade was more efficient in suppressing TAM recruitment, reducing tumor vasculature and improving survival compared with monotherapy of VEGF blockade (136). Here, VEGFA is linked to glioblastoma.